Eric S Leifer1, Catherine R Mikus, Laura Karavirta, Benjamin D Resnick, William E Kraus, Keijo Häkkinen, Conrad P Earnest, Jerome L Fleg. 1. 1Office of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, MD; 2Division of Cardiology, Duke University Medical Center, Durham, NC; 3Department of Biology of Physical Activity, University of Jyväskylä, Jyväskylä, FINLAND; 4Department of Medicine, Duke University Medical Center, Durham, NC; 5Department of Health and Kinesiology, Texas A&M University, College Station, TX; 6Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD.
Abstract
PURPOSE:Aerobic exercise training in sedentary individuals improves physical fitness and various cardiovascular (CV) biomarkers. Nevertheless, there has been controversy as to whether exercise training may adversely affect some biomarkers in a small segment of the population. The purpose of this study was to investigate whether clinically significant worsening of CV biomarkers was more prevalent among individuals randomized to a supervised endurance training program as compared with those randomized to a control condition. METHODS: Baseline and end of study measurements of fasting insulin (FI), triglycerides (TG), resting systolic blood pressure (SBP), and HDL cholesterol (HDL-C) were obtained on 1188 healthy sedentary subjects from 4 clinical studies. Each study randomized subjects to 4- to 6-month supervised aerobic exercise programs or to a control group of no supervised exercise training. For each of the 4 CV biomarkers, we calculated the respective proportions of control and exercise group subjects whose baseline-to-follow-up changes were greater than or equal to previously reported adverse change (AC) thresholds. Those thresholds were increases of 24 pmol · L(-1) or greater for FI, 0.42 mmol · L(-1) or greater for TG, 10 mm Hg or greater for SBP, and a decrease of 0.12 mmol · L(-1) or greater for HDL-C. RESULTS: The respective proportions of subjects meeting the AC threshold in the control and exercise groups were 15.2% versus 9.6% (P = 0.02) for FI, 14.9% versus 13.1% (P = 0.37) for TG, 16.9% versus 15.8% (P = 0.52) for SBP, and 28.6% versus 22.5% (P = 0.03) for HDL-C. All were nonsignificant at the 0.0125 Bonferroni threshold adjusting for multiple comparisons. CONCLUSIONS: These findings do not support the concept that aerobic exercise training increases the risk of adverse changes in the CV biomarkers we studied.
RCT Entities:
PURPOSE: Aerobic exercise training in sedentary individuals improves physical fitness and various cardiovascular (CV) biomarkers. Nevertheless, there has been controversy as to whether exercise training may adversely affect some biomarkers in a small segment of the population. The purpose of this study was to investigate whether clinically significant worsening of CV biomarkers was more prevalent among individuals randomized to a supervised endurance training program as compared with those randomized to a control condition. METHODS: Baseline and end of study measurements of fasting insulin (FI), triglycerides (TG), resting systolic blood pressure (SBP), and HDL cholesterol (HDL-C) were obtained on 1188 healthy sedentary subjects from 4 clinical studies. Each study randomized subjects to 4- to 6-month supervised aerobic exercise programs or to a control group of no supervised exercise training. For each of the 4 CV biomarkers, we calculated the respective proportions of control and exercise group subjects whose baseline-to-follow-up changes were greater than or equal to previously reported adverse change (AC) thresholds. Those thresholds were increases of 24 pmol · L(-1) or greater for FI, 0.42 mmol · L(-1) or greater for TG, 10 mm Hg or greater for SBP, and a decrease of 0.12 mmol · L(-1) or greater for HDL-C. RESULTS: The respective proportions of subjects meeting the AC threshold in the control and exercise groups were 15.2% versus 9.6% (P = 0.02) for FI, 14.9% versus 13.1% (P = 0.37) for TG, 16.9% versus 15.8% (P = 0.52) for SBP, and 28.6% versus 22.5% (P = 0.03) for HDL-C. All were nonsignificant at the 0.0125 Bonferroni threshold adjusting for multiple comparisons. CONCLUSIONS: These findings do not support the concept that aerobic exercise training increases the risk of adverse changes in the CV biomarkers we studied.
Authors: W E Kraus; C E Torgan; B D Duscha; J Norris; S A Brown; F R Cobb; C W Bales; B H Annex; G P Samsa; J A Houmard; C A Slentz Journal: Med Sci Sports Exerc Date: 2001-10 Impact factor: 5.411
Authors: Normand G Boulé; S John Weisnagel; Timo A Lakka; Angelo Tremblay; Richard N Bergman; Tuomo Rankinen; Arthur S Leon; James S Skinner; Jack H Wilmore; D C Rao; Claude Bouchard Journal: Diabetes Care Date: 2005-01 Impact factor: 19.112
Authors: E W Daw; M A Province; J Gagnon; J P Despres; C Bouchard; A S Leon; J S Skinner; J H Wilmore; D C Rao Journal: Ann Epidemiol Date: 1997-10 Impact factor: 3.797
Authors: Lori A Bateman; Cris A Slentz; Leslie H Willis; A Tamlyn Shields; Lucy W Piner; Connie W Bales; Joseph A Houmard; William E Kraus Journal: Am J Cardiol Date: 2011-07-07 Impact factor: 2.778
Authors: Angela M Thompson; Catherine R Mikus; Ruben Q Rodarte; Brandy Distefano; Elisa L Priest; Erin Sinclair; Conrad P Earnest; Steven N Blair; Timothy S Church Journal: Contemp Clin Trials Date: 2007-10-11 Impact factor: 2.226
Authors: Gina M Morss; Alex N Jordan; James S Skinner; Andrea L Dunn; Timothy S Church; Conrad P Earnest; James B Kampert; Radim Jurca; Steven N Blair Journal: Med Sci Sports Exerc Date: 2004-02 Impact factor: 5.411
Authors: Eva Obarzanek; Michael A Proschan; William M Vollmer; Thomas J Moore; Frank M Sacks; Lawrence J Appel; Laura P Svetkey; Marlene M Most-Windhauser; Jeffrey A Cutler Journal: Hypertension Date: 2003-09-02 Impact factor: 10.190
Authors: Jacob L Barber; Jonathan J Ruiz-Ramie; Jeremy M Robbins; Robert E Gerszten; Arthur S Leon; D C Rao; James S Skinner; Claude Bouchard; Mark A Sarzynski Journal: Br J Sports Med Date: 2021-02-22 Impact factor: 13.800